Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
Clinical and Translational Radiation Oncology|December 9, 2024
Fractionated stereotactic radiotherapy of brainstem metastases - Clinical outcome and prognostic factorsAnna Krämer, Laura Hahnemann, Fabian Schunn, et al.
Radiation Oncology (London, England)|May 25, 2022
Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3)Sebastian Regnery, Jonas Ristau, Fabian Weykamp, et al.
Frontiers in Oncology|December 18, 2020
Consolidation Immunotherapy After Platinum-Based Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer-Cross-Sectional Study of Eligibility and Administration RatesTanja Eichkorn, Farastuk Bozorgmehr, Sebastian Regnery, et al.
Cancers|June 24, 2022
Methods of Esthetic Assessment after Adjuvant Whole-Breast Radiotherapy in Breast Cancer Patients: Evaluation of the BCCT.core Software and Patients' and Physicians' Assessment from the Randomized IMRT-MC2 TrialTobias Forster, Clara Köhler, Melissa Dorn, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 15, 2020
Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trialDavid Krug, Reinhard Vonthein, Andreas Schreiber, et al.
International Journal of Radiation Oncology, Biology, Physics|December 15, 2020
Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial)Juliane Hörner-Rieber, Tobias Forster, Adriane Hommertgen, et al.
Trials|July 18, 2018
Whole brain radiation therapy alone versus radiosurgery for patients with 1-10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trialDenise Bernhardt, Adriane Hommertgen, Daniela Schmitt, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2023
To fly or not to fly: Stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomesSebastian Regnery, Efthimios Katsigiannopulos, Philipp Hoegen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 4, 2021
Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trialTobias Forster, Adriane Hommertgen, Matthias Felix Häfner, et al.
Radiation Oncology (London, England)|May 4, 2023
Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced: the PUMA trialSebastian Regnery, Chiara de Colle, Chukwuka Eze, et al.
Pageof 13